A different study opposes our results supporting that CYP27A1 and CYP2R1 enzyme expression, as well as the ability to hydroxylize vitamin D3, are well persevered in NASH and do not contribute to lowered serum 25(OH)D levels [33]. The gene discussed is CYP27A1; the disease is metabolic dysfunction-associated steatohepatitis.